M2 PRESSWIRE-September 5, 2019-: Innovations in Medical Device Implants, Neurostimulation
, Surgical Interventions, and Smart Diagnostics, 2019 Study
Release date- 26082019 - PLANO - Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation
medical device company, today announced that its Board of Directors has decided to explore potential strategic alternatives to enhance shareholder value.
Helius Medical Technologies reported that a scientific paper entitled Human Translingual Neurostimulation
Alters Resting Brain Activity in High-density EEG was published in the latest edition of the peer reviewed Journal of NeuroEngineering and Rehabilitation.
- A new national coverage determination for US-based pharmaceutical company Abbott's (NYSE: ABT) dorsal root ganglion neurostimulation
pain therapy through US-based health insurer Aetna, the company said.
Abbott announced a new national coverage determination for the company's dorsal root ganglion (DRG) neurostimulation
pain therapy through Aetna, a leading health benefits company in the United States.
company BlueWind Medical revealed on Monday the appointment of Roger R.
SPRINT delivers neurostimulation
benefits without requiring a permanent implant.
The number of new disease states that can be addressed with implantable neurostimulation
devices continues to grow.
In the study, 73 patients who were experiencing physical withdrawal from opioids used the neurostimulation
8 September 2017 - Kentucky, US-based bioelectronics medical device company Nexeon MedSystems (OTCQB: NXNN) (NMB) has exercised its option to acquire Belgium-based neurostimulation
product developer Nexeon Medsystems Belgium, SPRL, the company said.